The Benefit of FVIII Measurement: Tailored Treatment with Obi-1, a Recombinant Porcine Sequence Factor VIII, in Subjects with Acquired Hemophilia a

被引：0
|
作者：
Oladapo, Abiola [1 ]
Epstein, Joshua [1 ]
Novack, Aaron [1 ]
Farin, Heinrich D. [1 ]
机构：
[1] Baxter Healthcare Corp, Westlake Village, CA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Overview of the structure and manufacturing process for OBI-1, a recombinant porcine sequence, factor VIII for the treatment of acquired hemophilia A
    Wojciechowski, Peter
    Lai, Chee Kong
    Xiong, Yi
    Deer, Frank
    [J]. HAEMOPHILIA, 2014, 20 : 181 - 181
  • [2] Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A
    Kruse-Jarres, R.
    St-Louis, J.
    Greist, A.
    Shapiro, A.
    Smith, H.
    Chowdary, P.
    Drebes, A.
    Gomperts, E.
    Bourgeois, C.
    Mo, M.
    Novack, A.
    Farin, H.
    Ewenstein, B.
    [J]. HAEMOPHILIA, 2015, 21 (02) : 162 - 170
  • [3] Efficacy of OBI-1, a recombinant porcine sequence FVIII product, in animal models of hemophilia A
    Schiviz, Alexandra
    Piskernik, Christina
    Leidenmuehler, Peter
    Muchitsch, Eva-Maria
    Hoellriegl, Werner
    [J]. HAEMOPHILIA, 2014, 20 : 2 - 2
  • [4] Recombinant Porcine Factor VIII, Obi-1, Successfully Controlled Gastrointestinal Bleeding in a Patient with Acquired Hemophilia A
    Riaz, Muhammad Kashif
    Girnius, Saulius
    Palascak, Joseph Edward
    [J]. BLOOD, 2015, 126 (23)
  • [5] Treatment of serious bleeds with an antihaemophilic factor VIII (recombinant), porcine sequence (OBI-1) in patients with acquired haemophilia A
    Kruse-Jarres, R.
    St-Louis, J.
    Greist, A.
    Shapiro, A.
    Smith, H.
    Chowdary, P.
    Drebes, A.
    Gomperts, E.
    Bourgeois, C.
    Mo, M.
    Novack, A.
    Farin, H.
    Ewenstein, B.
    [J]. HAEMOPHILIA, 2015, 21 : 62 - 62
  • [6] The Effect of Inhibitory Antibodies on Acute Treatment of Bleeding Episodes with OBI-1, an Antihemophilic Factor VIII (recombinant), Porcine Sequence, in Patients with Acquired Hemophilia A
    Farin, Heinrich D.
    Novack, Aaron
    Mo, Min
    Bourgeois, Christelle
    Horling, Frank M.
    Ewenstein, Bruce M.
    [J]. BLOOD, 2014, 124 (21)
  • [7] Preclinical safety of OBI-1, a recombinant porcine sequence FVIII product
    Schiviz, Alexandra
    Hoellriegl, Werner
    Piskernik, Christina
    Leidenmuehler, Peter
    Muchitsch, Eva-Maria
    Dietrich, Barbara
    [J]. HAEMOPHILIA, 2014, 20 : 2 - 2
  • [8] Recombinant porcine sequence factor VIII (OBI-1): Results from a prospective clinical study investigating the treatment of serious bleeds in patients with acquired hemophilia A
    Kruse-Jarres, R.
    St-Louis, J.
    Greist, A.
    Shapiro, A.
    Smith, H.
    Chowdary, P.
    Drebes, A.
    Gomperts, E.
    Chapman, M.
    Mo, M.
    Novack, A.
    Farin, H.
    [J]. HAEMOPHILIA, 2014, 20 : 1 - 1
  • [9] OBI-1, porcine recombinant Factor VIII for the potential treatment of patients with congenital hemophilia A and alloantibodies against human Factor VIII
    Toschi, Vincenzo
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (05) : 617 - 625
  • [10] Efficacy and safety of B-domain deleted recombinant porcine factor VIII (OBI-1) in the treatment of acquired hemophilia A: interim results
    Greist, A.
    Shapiro, A.
    Kruse-Jarres, R.
    St Louis, J.
    Smith, H.
    Gomperts, E.
    [J]. HAEMOPHILIA, 2012, 18 : 1 - 1
12345